New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion.

Abstract:

BACKGROUND:Adequate vitamin D and calcium nutrition play a critical role in the maintenance of musculoskeletal health and are considered the first step in osteoporosis treatment. ROUNDTABLE DISCUSSION:In February 2008 Merck Sharp & Dohme sponsored a 2-day, evidence-based expert panel on the benefits of vitamin D for the patient with osteoporosis and the role of vitamin D in combination with antiresorptive therapy for the management of osteoporosis. One of the primary objectives of the meeting was to review new data on the optimal serum 25-hydroxy vitamin D [25(OH)D] levels. The symposium was attended by 29 researchers and clinicians from Europe and the Middle East. The discussion focused on optimizing vitamin D and calcium nutrition and reducing falls and fractures in osteoporotic patients. CONCLUSIONS:Current evidence and expert opinion suggests that optimal serum 25(OH)D concentrations should be at least 50 nmol/L (20 ng/mL) in all individuals. This implies a population mean close to 75 nmol/L (30 ng/mL). In order to achieve this level, vitamin D intake of at least 20 microg daily is required. There is a wider therapeutic window for vitamin D than previously believed, and doses of 800 IU per day, regardless of sun exposure, season or additional multivitamin use, appear to present little risk of toxicity. Apart from fracture and fall prevention, optimization of vitamin D status may also have additional general health benefits. Based on newly emerging data regarding calcium supplementation, and recommendations for increased vitamin D intake, the current recommendations for calcium intake in postmenopausal women may be unnecessarily high. In addition to vitamin D and calcium, treatment of patients with osteoporosis at high risk of fractures should also include pharmacologic agents with proven vertebral and non-vertebral fracture efficacy.

journal_name

Curr Med Res Opin

authors

Roux C,Bischoff-Ferrari HA,Papapoulos SE,de Papp AE,West JA,Bouillon R

doi

10.1185/030079908x301857

subject

Has Abstract

pub_date

2008-05-01 00:00:00

pages

1363-70

issue

5

eissn

0300-7995

issn

1473-4877

pii

4491

journal_volume

24

pub_type

杂志文章,评审
  • Impact of methodological choices on a meta-analysis of real-world evidence comparing non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.

    abstract::Objective: The aim of this study was to investigate the impact of methodological choices in a meta-analysis of real-world evidence (RWE) comparing three non-vitamin-K antagonist oral anticoagulants with vitamin K antagonists (VKAs) for the treatment of patients with non-valvular atrial fibrillation (NVAF). Methods: Th...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1080/03007995.2019.1647020

    authors: Briere JB,Wu O,Bowrin K,Millier A,Toumi M,Taieb V,Levy P,Coleman CI

    更新日期:2019-11-01 00:00:00

  • Risk factors associated with myocardial infarction in venous thromboembolism patients.

    abstract:BACKGROUND:Although risk factors for MI have been described in the general population, there is a lack of data on the assessment of risk factors associated with MI in venous thromboembolism (VTE) patients. OBJECTIVE:The purpose of this study was to identify risk factors associated with MI in VTE patients. PATIENTS AN...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.852525

    authors: Laliberté F,Nutescu EA,Lefebvre P,Rondeau-Leclaire J,Bookhart BK,LaMori JC,Damaraju CV,Schein J,Kaatz S

    更新日期:2014-01-01 00:00:00

  • Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide.

    abstract:OBJECTIVE:The objectives of this article are to review the pathophysiology of type 2 diabetes mellitus (T2DM), present the rationale for a pathophysiologically based treatment approach for patients with T2DM and discuss the role of the therapeutic combination of pioglitazone and exenatide in the management of T2DM. ME...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802390795

    authors: Schwartz S

    更新日期:2008-11-01 00:00:00

  • Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine.

    abstract:OBJECTIVE:Migraine is a chronic, disabling neurological disease affecting >1 billion people worldwide. Migraine remains undertreated in Asia, including Taiwan. Galcanezumab is a humanized monoclonal antibody that selectively binds calcitonin gene-related peptide, a peptide firmly established in the pathophysiology of m...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1815181

    authors: Yang CP,Lee CF,Dell'Agnello G,Hundemer HP,Lipsius S,Wang SJ

    更新日期:2020-10-01 00:00:00

  • Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

    abstract:OBJECTIVE:Significant race and ethnic disparities exist in diabetes-related health care. Using a nationally representative database, we sought to determine if use of thiazolidinediones (TZDs) differs by race and ethnicity. As a secondary objective, we sought to determine if race and ethnicity is associated with use of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X167354

    authors: Aquilante CL,Zhang W,McCollum M

    更新日期:2007-03-01 00:00:00

  • Recent advances in breast cancer: the 27th ESMO Congress 2002.

    abstract::Breast cancer was the focus of several presentations during the 27th European Society of Medical Oncology (ESMO) Congress held in Nice. Fulvestrant seems to be equally effective to tamoxifen as a first-line therapy in hormone-sensitive advanced breast cancer in postmenopausal women. However, it may be more effective t...

    journal_title:Current medical research and opinion

    pub_type:

    doi:

    authors: Mokbel K

    更新日期:2003-01-01 00:00:00

  • Adherence and persistence analysis after three years in real-life of inhalation therapies used in the treatment of COPD.

    abstract:INTRODUCTION:Low adherence and persistence values, which indicate real-life efficiency, have been widely reported in patients suffering from COPD (Chronic Obstructive Pulmonary Disease). Poor adherence may be related to treatment dosage, thus, simplifying the dosing regimen might improve adherence. The objective of the...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1841617

    authors: Romagnoli A,Santoleri F,Costantini A

    更新日期:2020-12-01 00:00:00

  • Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants.

    abstract:OBJECTIVES:Compare costs and healthcare resource utilization (HCRU) among newly-diagnosed non-valvular atrial fibrillation (NVAF) patients newly treated with dabigatran vs apixaban, rivaroxaban, or warfarin. METHODS:Newly-diagnosed adult NVAF patients initiating dabigatran, apixaban, rivaroxaban, or warfarin (index ev...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2017.1409425

    authors: Gilligan AM,Franchino-Elder J,Song X,Wang C,Henriques C,Sainski-Nguyen A,Wilson K,Smith DM,Sander S

    更新日期:2018-02-01 00:00:00

  • How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.

    abstract:BACKGROUND:In treating migraine sufferers, physicians can choose from among seven triptans with different attributes. OBJECTIVE:To develop a system for selecting an oral triptan based on treatment priorities of migraine sufferers, neurologists, and primary care physicians (PCPs) in the United States, and evidence-base...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/030079905X36387

    authors: Lipton RB,Cutrer FM,Goadsby PJ,Ferrari MD,Dodick DW,McCrory D,Liberman JN,Williams P

    更新日期:2005-03-01 00:00:00

  • Comparison of sustained-release clonidine and long-acting propranolol in the treatment of hypertension.

    abstract::A double-blind crossover trial was undertaken to compare the efficacy of sustained-release clonidine and long-acting propranolol in the treatment of 20 patients (8 males and 12 females) with sustained hypertension. Each patient was stabilized with metoprolol with or without diuretic therapy prior to admission to the t...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998209109778

    authors: Rodrigues E,Lawson AA

    更新日期:1982-01-01 00:00:00

  • Efficacy and safety of ultrasound-guided percutaneous polidocanol sclerotherapy in benign predominantly cystic thyroid nodules: a prospective study.

    abstract:OBJECTIVE:To evaluate the efficacy and safety of percutaneous polidocanol injection (PPI) in treatment of predominantly cystic thyroid nodules. MATERIALS AND METHODS:This prospective study included 111 patients with 122 benign predominantly cystic thyroid nodules inducing pressure symptoms or cosmetic problems. The no...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,随机对照试验

    doi:10.1080/03007995.2017.1325732

    authors: Gong X,Zhou Q,Chen S,Wang F,Wu W,Chen X

    更新日期:2017-08-01 00:00:00

  • Undertreatment of hypercholesterolemia.

    abstract::Abstract Recent guidelines recommend strict goals for low-density lipoprotein cholesterol (LDL-C) (1.8-2.6 mmol/L; 70-100 mg/dL). However, these goals are not always met and many primary and secondary prevention patients are not optimally controlled. Both the under-prescription of lipid-lowering medication and lack of...

    journal_title:Current medical research and opinion

    pub_type: 评论,社论

    doi:10.1185/03007990903512396

    authors: Daskalopoulou SS,Doonan RJ,Mikhailidis DP

    更新日期:2010-02-01 00:00:00

  • Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.

    abstract:OBJECTIVE:To compare the risk of developing uveitis in patients initiating anti-tumor necrosis factor (anti-TNF) agents (adalimumab, etanercept, and infliximab) for ankylosing spondylitis (AS). METHODS:Anti-TNF-naive patients with a diagnosis of AS and without a history of uveitis (N = 2115) who subsequently initiated...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2014.969368

    authors: Wendling D,Joshi A,Reilly P,Jalundhwala YJ,Mittal M,Bao Y

    更新日期:2014-12-01 00:00:00

  • Availability of post-trial access in clinical trials: a review of clinical trial protocols submitted to the research ethics board of the University of the Philippines Manila.

    abstract::Objectives: Ethics guidelines such as the Declaration of Helsinki and the CIOMS International Ethical Guidelines for Health-related Research Involving Humans require the sponsors, in cooperation with relevant stakeholders, to provide post-trial access (PTA) to intervention and knowledge, especially in clinical trials ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2019.1644851

    authors: Jimenez EB,Virtudazo JMP,Torres CE,Bernabe RD

    更新日期:2019-11-01 00:00:00

  • Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.

    abstract:OBJECTIVE:Most patients with hypertension require antihypertensive combination therapy to achieve BP control. This study investigated the safety and efficacy of the direct renin inhibitor aliskiren combined with the calcium channel blocker amlodipine. METHODS:Overall, 556 patients with hypertension (msDBP > or =95-<11...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990902785845

    authors: Littlejohn TW 3rd,Trenkwalder P,Hollanders G,Zhao Y,Liao W

    更新日期:2009-04-01 00:00:00

  • Validation of the EQ-5D in patients with a history of acute coronary syndrome.

    abstract:OBJECTIVE:To analyze the construct validity of the EQ-5D in patients with acute coronary syndromes (ACS). METHODS:All ACS-diagnosed patients discharged from a university-affiliated hospital during a 3-year period were mailed a questionnaire that included the EQ-5D and the SF-8. The EQ-5D includes a visual analogue sca...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079905X56349

    authors: Ellis JJ,Eagle KA,Kline-Rogers EM,Erickson SR

    更新日期:2005-08-01 00:00:00

  • Double-blind trials of clemastine ('Tavegil') in allergic rhinitis.

    abstract::Two double-blind randomised trials are reported comparing the effectiveness of the antihistamines, clemastine and chlorpheniramine in comparable doses, in relieving the symptoms of allergic rhinitis. In the first trial, treating 58 adults seen in a general practice, both drugs were prescribed in tablet form; l mg. cle...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997509113659

    authors: Todd G,Hopkins P,Maclay WP

    更新日期:1975-01-01 00:00:00

  • The humanistic burden of postpartum depression: a systematic literature review.

    abstract:OBJECTIVE:Postpartum depression (PPD) is the most common medical complication of childbirth. PPD can be disabling, with potential negative effects on maternal health-related quality-of-life (HRQoL) as well as on children and partners. The objective of this study was to systematically review and summarize recently publi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2018.1552039

    authors: Moore Simas TA,Huang MY,Patton C,Reinhart M,Chawla AJ,Clemson C,Eldar-Lissai A

    更新日期:2019-03-01 00:00:00

  • Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin.

    abstract:OBJECTIVE:Statin dose, adherence, and cardiovascular (CV) outcomes are important factors when considering switching statin therapies. The objective of the study was to compare CV event rates and risk in managed care patients receiving atorvastatin versus those switched to simvastatin from atorvastatin. METHODS:Patient...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.802229

    authors: Jacobson TA,Wertz DA,Kuznik A,Cziraky M

    更新日期:2013-07-01 00:00:00

  • Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.

    abstract:OBJECTIVE:To determine whether the efficacy and tolerability of adjunctive lamotrigine differ as a function of whether persons with mental retardation and refractory epilepsy resided in institutions or the community. RESEARCH DESIGN AND METHODS:The analysis was retrospective and employed data from a previously publish...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079906X96281

    authors: Sunder TR,McKee JR,Hammer AE,Vuongc A

    更新日期:2006-04-01 00:00:00

  • Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.

    abstract:AIM:To assess the efficacy of a strategy to improve vascular risk management in patients with type 2 diabetes mellitus (T2DM). METHODS:This was a pilot best practice implementation enhancement programme that enrolled 578 patients with T2DM. A baseline visit was followed by a concerted effort from previously trained ph...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990903073035

    authors: Athyros VG,Hatzitolios A,Karagiannis A,Didangelos TP,Iliadis F,Dolgyras S,Vosnakidis T,Vasiliadis P,Malias I,Tziomalos K,Samouilidou M,Mikhailidis DP,INDEED Collaborative Group.

    更新日期:2009-08-01 00:00:00

  • Controlled-release naproxen compared with isoxicam in patients with osteoarthritis.

    abstract::The therapeutic efficacy and tolerability of a new controlled-release 1000 mg tablet of naproxen (naproxen CR) were compared with 200 mg isoxicam in 100 out-patients with osteoarthritis. Medications were administered once daily for 4 weeks in a controlled, randomized, double-blind, parallel trial. Patients were assess...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998809111127

    authors: Frankhof W

    更新日期:1988-01-01 00:00:00

  • Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy.

    abstract:BACKGROUND:For the prevention of chemotherapy-induced febrile aplasia, a single injection of pegfilgrastim per cycle has the same efficacy as six to ten injections of conventional granulocyte colony-stimulating factor (G-CSF). However, there are few data on the economic impact of pegfilgrastim use, especially in the co...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990902918156

    authors: Tan Sean P,Chouaid C,Hettler D,Baud M,Hejblum G,Tilleul P

    更新日期:2009-06-01 00:00:00

  • A comparative trial of ketoprofen and ibuprofen in patients with rheumatic disease.

    abstract::A comparative controlled study was carried out in 40 patients suffering from rheumatoid arthritis, osteoarthrosis or ankylosing spondylitis to assess the efficacy of ketoprofen and ibuprofen. Patients were allocated at random to receive either 100 mg ketoprofen twice daily or 400 mg ibuprofen 3-times daily over a peri...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997809111919

    authors: Saxena RP,Saxena U

    更新日期:1978-01-01 00:00:00

  • From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus.

    abstract:BACKGROUND:Elevated glucose blood levels are the key criteria for diagnosing diabetes mellitus (DM). Hyperglycaemia contributes to the pathophysiology associated with DM, including microvascular and possibly macrovascular disease. In spite of a wide range of pharmacological options available to reduce hyperglycaemia in...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802710422

    authors: Bays H

    更新日期:2009-03-01 00:00:00

  • Strategies to prevent type 2 diabetes.

    abstract::Type 2 diabetes mellitus is a public health problem of epidemic proportions and its prevalence is on the rise. The typical American born today has a one in three chance of developing type 2 diabetes. This diagnosis is associated with an adverse cardiovascular prognosis and is considered the risk equivalent of establis...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析,评审

    doi:10.1185/030079905X50606

    authors: Abuissa H,Bel DS,O'keefe JH Jr

    更新日期:2005-07-01 00:00:00

  • A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.

    abstract::Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the elderly, characterised by widespread loss of central cholinergic function. The only symptomatic treatment proven effective to date is the use of cholinesterase (ChE) inhibitors to augment surviving cholinergic activity. ChE inhibitors act on t...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/0300799039117057

    authors: Greig NH,Utsuki T,Yu Q,Zhu X,Holloway HW,Perry T,Lee B,Ingram DK,Lahiri DK

    更新日期:2001-01-01 00:00:00

  • Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.

    abstract:OBJECTIVE:To evaluate intraocular pressure (IOP)-lowering efficacy, tolerability, and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% (Ganfort) among German patients. METHODS:Multicenter, observational, open-label study of patients with primary open angle glaucoma or ocular hypertension (n = 606)...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007990902816947

    authors: Feuerhake C,Buchholz P,Kimmich F

    更新日期:2009-04-01 00:00:00

  • The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

    abstract:OBJECTIVE:It has been acknowledged that patients who receive a beta-blocker or diuretic based regimen are at increased risk of developing new-onset diabetes. Recently, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been shown to decrease patients' odds of developing new-o...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析

    doi:10.1185/030079907X188044

    authors: Kuti EL,Baker WL,White CM

    更新日期:2007-06-01 00:00:00

  • Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.

    abstract::Doxofylline (7-(1,3-dioxalan-2-ylmethyl) theophylline) is a novel xanthine bronchodilator which differs from theophylline in that it contains a dioxalane group in position 7. Similarly to theophylline, its mechanism of action is related to the inhibition of phosphodiesterase activities, but in contrast it appears to h...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079901750120196

    authors: Dini FL,Cogo R

    更新日期:2001-01-01 00:00:00